Navigation Links
Osiris in Medical News

Former Executive at Genzyme Corp. and Osiris Therapeutics, Inc. to Head Business Advisory Board at Rx for Africa, Inc.

NEW YORK, April 13 /PRNewswire-FirstCall/ -- A top biotech executive, William Pursley, has agreed to become Chairman of Rx for Africa, Inc.'s (Pink Sheets: RXAF) newly created Business Advisory Board. For 25 years Mr. Pursley has held major executive positions in the biotech industry. In 1985 he j...

JDRF Partners with Osiris to evaluate an immunomodulatory cell therapy product for type 1 diabetes

JDRF Partners with Osiris on a Phase II Trial to Evaluate an Immunomodulatory Cell Therapy Product For Type 1 Diabetes New York, NY October 25, 2007 The Juvenile Diabetes Research Foundation announced today a partnership with Osiris Therapeutics, Inc. (NASDAQ:OSIR) to support a Phase II cli...

Biotech Osiris to go public

Baltimore biotech, the company that is known for being the sole manufacturer of the stem cell product, has made its plans known, about its intention to go public//. The company is slated to sell out nearly $80 million in shares, as per the papers filed with the Securities and Exchange Commission. ...

Long Term Supply of Osteocel(R) Plus Solidified Without Ownership of Processing Facility

...Vasive has accelerated the transfer of the processing of Osteocel Plus from osiris Therapeutics (Nasdaq: OSIR ) to its own exclusive supply chain. Sin...and consistent stream of supply. NuVasive will not assume ownership of the osiris tissue processing facility. NuVasive reiterates its previous guidance ...

Ongoing worldwide shortage of medical isotopes could threaten patient care, says expert

...ld's Mo-99 is produced by five commercial nuclear reactors NRU at Chalk River in Canada, HFR at Petten in The Netherland, BR-2 at Fleurus in Belgium, osiris at Saclay in France and SAFARI-1 at Pelindaba in South Africa. The UK has no facility for producing Mo-99 of its own. Until fairly recently, productio...

BullMarket.com Examines Stem Cell Stocks

...ibers with coverage of stem cell stocks, including Geron (Nasdaq: GERN ), osiris Therapeutics (Nasdaq: OSIR ), Cytori Therapeutics (Nasdaq: CYTX ), and ...ptions surrounding stem cell stocks? -- What are some of the positives osiris has going for it? -- What potential problem could Cytori run into? ...

NuVasive Announces Preliminary Unaudited Full Year 2008 Financial Results

...nge of $345 million to $350 million. Osteocel revenue in the fourth quarter 2008 included approximately $5 million in sales to former distributors of osiris Therapeutics, Inc. (Nasdaq: OSIR ). As the Company launches the Osteocel product through its exclusive sales force, it will not have the benefit of...

QRxPharma Expands Management Team with the Addition of Dr. Jesus Soriano as Executive Vice President

...o joining QRxPharma, Soriano was Senior Director of Business Development at osiris Therapeutics, Inc., and responsible for all business development activities... out-licensing and divestiture. During Dr. Soriano's tenure, Maryland-based osiris Therapeutics formed a $1.4 billion partnership with Genzyme Corp. for the d...

Stem Cell Product Commercialization Focus of Summit

...Inc. Novocell, Inc. ArunA Biomedical, Inc. NuVasive, Inc. BioE Corp. osiris Therapeutics, Inc. California Stem Cell, Inc. Progenitor Cell Therapy, Inc. Cellerix, S.A. SpineSmit...

Preliminary Lineup Set for 4th Annual Stem Cell Summit

... Arteriocyte, Inc. Novocell, Inc. BioE Corp. NuVasive, Inc. California Stem Cell, Inc. osiris Therapeutics, Inc. Cellerix, S.A. Progenitor Cell Therapy, Inc. Cognate BioServices, Inc. Stemagen Cytori Ther...
Osiris in Medical Technology

Pain Relief in Just One Visit with Genzyme's Synvisc-One

...ceuticals, Genzyme Biosurgery, Integra LifeSciences, LifeNet Health, Medtronic Spinal and Biologics, Musculoskeletal Transplant Foundation, Orthovita, osiris Therapeutics, Osteotech, RTI Biologics, sanofi-aventis, Smith & Nephew, Stryker, Synthes, Wright Medical Technology, and many more. Other reports ...

Heart Attack Patients Treated With Novel Stem Cell Therapy Experience Significant Improvement in Heart and Lung Function

...dical Center, we were able to conduct a study that was exceptionally well planned and executed” said C. Randal Mills Ph.D., President and CEO of osiris Therapeutics. “We were confident in the safety profile given our previous experience using the intravenous form of these stem cells to treat oth...
Osiris in Medical Products

Osiris

Description:... osiris is a system built around data management software and an imaging device that measures the inhibition zone size around an antibiotic disc. osiris offers built-in expertise for detection of potential errors and detection o...
Company:Bio-Rad Laboratories
Osiris in Biological News

Stem cell therapy shows promise in regenerating damaged muscle in heart attack patients

...em cells pre-formulated for intravenous delivery by the drug's manufacture, osiris Therapeutics. Patients were administered an infusion of either Provacel or...well planned and executed" said C. Randal Mills Ph.D., President and CEO of osiris Therapeutics. "We were confident in the safety profile given our previous e...
Osiris in Biological Technology

NuVasive Signs Definitive Agreement to Acquire Osteocel Biologics Business from Osiris Therapeutics

- Expands biologics platform for robust growth - - Includes proprietary adult stem cell bone graft product and processing facility - - Expects Osteocel(R) revenues of $15 million in 2008 and $25 million in 2009; no dilution to earnings per share in...

NeoStem Featured in Business Week; 'Promising' Adult Stem Cell Market Discussed in Fortune-CNNMoney.com Article

...tal Partners, a Pan-Asian private equity firm with deep connections across Asia, declared, "I believe investors are beginning to see that, compared to osiris -- which is the largest stem cell company with a market cap of around $425 million -- NBS is dramatically undervalued given its IP portfolio, product ...

AssureRx Adds New CEO

... the buyout of a New York Stock Exchange company to form MedPointe Pharmaceuticals. Mr. Burns was also a founder, chairman, president and CEO of osiris Therapeutics Inc., a public biotech company developing therapeutic stem-cell products for the regeneration of damaged or diseased tissues. Previously,...

Heart Hospital of Austin First Site in World to Test Efficacy of New Adult Stem Cell Therapy to Treat Damaged Heart Tissue in Phase II Trial

...o or animal. MSCs have the ability to develop into other types of cells and generate new tissue, including heart muscle. Prochymal(R) is a product of osiris Therapeutics, Inc. "There's a lot of enthusiasm in the cardiovascular community about the potential of stem cell therapies for treating heart dis...

Three Firms, Two Training Programs Garner Greater Baltimore Committee's 2009 Bioscience Awards

... Best New Product or Progress: C. Randal Mills, Ph.D., president and CEO, osiris Therapeutics, Inc. Mills' Columbia-based company has spent more than $300 million developing stem cell therapies. The funding has allowed osiris to complete clinical trials necessary to demonstrate the safety and efficac...

Greater Baltimore Committee to Announce Winners of 2009 Maryland Bioscience Awards at Ceremonies on March 12

...agement Corporation Fred E. Festa , chairman, president and CEO, W.R. Grace & Company Dr. C. Randal Mills , president and CEO, osiris Therapeutics, Inc. Dr. Bruce Thompson , chairman of the board and president, Clinical Trials and Surveys Corp. (C-TASC) Lea...

NuVasive Completes Acquisition of Osteocel Biologics Business

... surgical treatments for the spine, announced today that it has completed the previously announced acquisition of the Osteocel biologics business from osiris Therapeutics, Inc. (Nasdaq: OSIR ) for $35 million in cash, plus additional milestone-based contingent payments not to exceed $50 million in either c...

BioSpace Career Fair in Bethesda, Maryland Draws Hundreds of Industry Professionals

... biologists, chemists and many others attended to interview with some of the top biotechnology companies and pharmaceutical firms. Companies including osiris Therapeutics and SAIC-Frederick were hiring for biotech business development careers, pharmaceutical facility management jobs, cell biology careers, b...

Stem Cell Therapy to Skyrocket by 2017

...dvanced Cell Technologies, Arteriocyte, Blackstone Medical, Cytori Therapeutics, Geron, Harvest Technologies, International Stem Cell Corporation, and osiris Therapeutics. About Stem Cells Stem cells are primal cells that are derived from highly proliferative tissues. These cells are precursors to every o...
Other Tags
(Date:5/24/2015)... 24, 2015 Women’s Excellence ... pressure measurements in patients’ bladder and urethra. This provides ... it if they have reported symptoms of stress urinary ... Women’s Excellence in Bladder Control is a comprehensive center ... or problems with overall control of their bladder. The ...
(Date:5/24/2015)... 2015 The federal court overseeing ... has scheduled its next monthly Case Management Conference ... According to court documents filed in the U.S. ... will be convened on June 2, 2015, at ... Liability Litigation - MDL No. 2545) , “Our ...
(Date:5/24/2015)... Arizona (PRWEB) May 24, 2015 ... former Millennial Media strategy executive Jay Krihak as ... Medicx looks to ramp up its expertise and ... of the Pharmaceutical and Health sectors. , Krihak ... tech executive. Most recently, Krihak led sales planning ...
(Date:5/23/2015)... City, FL (PRWEB) May 23, 2015 On ... to build a new playground for Branches Florida City exactly ... the former play space in 2010. , A large fire ... new playground on May 23, 2010 in the middle of ... watched. The fire was later declared arson even though it ...
(Date:5/23/2015)... (PRWEB) May 23, 2015 With the ... businesses, are finding it increasingly difficult to provide their ... fail to provide adequate insurance for employees stand to ... been such an integral part of a business’s success ... healthcare for businesses, Online USA Doctors has created a ...
Breaking Medicine News(10 mins):Health News:Testosterone Lawsuit Attorneys at Bernstein Liebhard LLP Look Ahead to June Conference in Federal Multidistrict Litigation 2Health News:Testosterone Lawsuit Attorneys at Bernstein Liebhard LLP Look Ahead to June Conference in Federal Multidistrict Litigation 3Health News:Medicx Media Solutions Expands Executive Team 2Health News:Five Years After Fire, Branches Rebuilds Playground 2Health News:Online USA Doctors Now Offers Cost-Saving Alternative Healthcare for Businesses 2Health News:Online USA Doctors Now Offers Cost-Saving Alternative Healthcare for Businesses 3
(Date:5/11/2015)... Calif. , May 11, 2015  Synaptics ... of human interface solutions, today announced the appointment ... President and Chief Financial Officer, reporting to ... replaces Synaptics, current Chief Financial Officer, Kathleen ... 2014. Mr. Ali brings extensive ...
(Date:5/11/2015)... 2015 Curemark LLC, a privately held drug ... new Phase III double blind, randomized, placebo-controlled clinical trial ... on all children ages 3-8 with Autism. Previously, Curemark ... double blinded clinical trial for CM-AT in children ages ... digestive enzyme chymotrypsin. This new trial will help determine ...
(Date:5/8/2015)... 2015 Synaptics Inc. (NASDAQ: SYNA ), the ... of the executive management team will present at the following ... and Telecom Conference Date: May 18, 2015 Time: ... MA Cowen and Company Technology, Media ... Location: The New York Palace Hotel, New York, ...
Breaking Biology News(10 mins):Synaptics Appoints Wajid Ali as Senior Vice President and Chief Financial Officer 2Curemark, LLC, Launches New Phase III Trial in Expanded Population of Children with Autism 2Synaptics to Present at Upcoming Investor Conferences 2
Other Contents